当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析 - 现金流量表

迪哲医药-U

(688192)

  

流通市值:256.16亿  总市值:258.35亿
流通股本:4.61亿   总股本:4.65亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金526,503,971.43259,026,446.25784,586,671.73559,618,110.76
  收到其他与经营活动有关的现金12,673,381.5710,039,738.6961,540,755.9335,498,609.25
  经营活动现金流入小计539,177,353269,066,184.94846,127,427.66595,116,720.01
  购买商品、接受劳务支付的现金286,219,053.25170,800,963.71503,149,726.41365,715,963.02
  支付给职工以及为职工支付的现金333,425,918.65198,307,746.99592,176,224.91434,636,966.7
  支付的各项税费47,459,426.822,003,278.540,355,616.6513,533,240.17
  支付其他与经营活动有关的现金146,380,736.5878,431,826.89298,770,648.26205,287,398.1
  经营活动现金流出小计813,485,135.28469,543,816.091,434,452,216.231,019,173,567.99
  经营活动产生的现金流量净额-274,307,782.28-200,477,631.15-588,324,788.57-424,056,847.98
二、投资活动产生的现金流量:
  收回投资收到的现金3,643,441,245.911,896,479,023.29,968,752,061.497,282,902,008.73
  处置固定资产、无形资产和其他长期资产收回的现金净额95,000-8,165.198,032.95
  投资活动现金流入小计3,643,536,245.911,896,479,023.29,968,760,226.687,282,910,041.68
  购建固定资产、无形资产和其他长期资产支付的现金47,297,105.8934,913,521.14170,469,026.06149,943,303.92
  投资支付的现金3,541,000,0001,955,000,00010,997,000,0007,585,000,000
  投资活动现金流出小计3,588,297,105.891,989,913,521.1411,167,469,026.067,734,943,303.92
  投资活动产生的现金流量净额55,239,140.02-93,434,497.94-1,198,708,799.38-452,033,262.24
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,776,367,935.511,776,367,935.51
  取得借款收到的现金434,280,000387,080,000810,717,810.54557,217,810.54
  收到其他与筹资活动有关的现金38,228,080.5338,228,080.5317,057,750-
  筹资活动现金流入小计472,508,080.53425,308,080.532,604,143,496.052,333,585,746.05
  偿还债务支付的现金310,924,130180,305,800711,907,015.12639,753,685.12
  分配股利、利润或偿付利息支付的现金16,273,530.627,599,785.9832,891,742.8525,979,444.09
  支付其他与筹资活动有关的现金38,259,163.9411,056,291.8230,659,846.2726,944,199.24
  筹资活动现金流出小计365,456,824.56198,961,877.8775,458,604.24692,677,328.45
  筹资活动产生的现金流量净额107,051,255.97226,346,202.731,828,684,891.811,640,908,417.6
四、汇率变动对现金及现金等价物的影响-265,176.13-158,619.01-394,408.41-223,484.38
五、现金及现金等价物净增加额-112,282,562.42-67,724,545.3741,256,895.45764,594,823
  加:期初现金及现金等价物余额291,146,638.08291,146,638.08249,889,742.63249,889,742.63
  期末现金及现金等价物余额178,864,075.66223,422,092.71291,146,638.081,014,484,565.63
补充资料:
  净利润-213,095,536.85--768,517,444.68-
  固定资产和投资性房地产折旧15,889,565.67-11,960,028.37-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧15,889,565.67-11,960,028.37-
  无形资产摊销16,538,725.17-33,340,462.44-
  长期待摊费用摊销1,661,379.03-7,861,748.29-
  处置固定资产、无形资产和其他长期资产的损失-84,070.8--279.52-
  固定资产报废损失314.61---
  公允价值变动损失-13,673,367.04--25,326,758.27-
  财务费用16,757,042.12-31,610,196.5-
  存货的减少-5,949,072.09-7,165,303.32-
  经营性应收项目的减少-59,273,756.23--114,025,471.8-
  经营性应付项目的增加-53,330,696.87-129,375,305.25-
  其他8,296,902.29-73,647,515.03-
  现金的期末余额178,864,075.66-291,146,638.08-
  减:现金的期初余额291,146,638.08-249,889,742.63-
  现金及现金等价物的净增加额-112,282,562.42-41,256,895.45-
公告日期2026-08-212026-04-302026-03-312025-10-31
审计意见(境内)标准无保留意见
TOP↑